Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Global Health & Medicine
|
March 16, 2022
Report on the nature, characteristics, and outcomes of the Japanese healthcare system
Tatsuya Kondo,
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
March 20, 2010
[Development and evaluation of new drugs and medical devices in Japan--standpoint of regulatory agency]
Hiroshi Maruyama, Tatsuya Kondo
Studies in Health Technology and Informatics
|
October 4, 2007
Risk management and measuring productivity with POAS--point of act system
Masanori Akiyama, Tatsuya Kondo
The Journal of Biological Chemistry
|
June 18, 2004
Altered insulin signaling in retinal tissue in diabetic states
Tatsuya Kondo, C Ronald Kahn
Nihon Hoshasen Gijutsu Gakkai Zasshi
|
October 29, 2025
[Proposal of a Mathematical Model for Motion Blur in MRI Images]
Tatsuya Kondo, Hiroaki Saito, Tsutomu Kanazawa
Masui. the Japanese Journal of Anesthesiology
|
October 2, 2015
[Anesthetic Management of a Patient for Total Gastrectomy after Coronary Artery Bypass Grafting Using the Right Gastroepiploic Artery]
Hanae Maejima, Gaku Inagawa, Tatsuya Kondo
Clinical Pharmacology and Therapeutics
|
August 9, 2012
International vision and strategy for drug regulatory authority: the PMDA's international vision
Toshiyoshi Tominaga, Yuki Ando, Tatsuya Kondo
Medical Science Educator
|
May 12, 2025
Pilot Study on Using Large Language Models for Educational Resource Development in Japanese Radiological Technologist Exams
Tatsuya Kondo, Masashi Okamoto, Yohan Kondo
Molecular and Cellular Biology
|
June 1, 2004
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
Kohjiro Ueki, Tatsuya Kondo, C Ronald Kahn
Journal of Diabetes Investigation
|
August 30, 2022
Potential of a glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
Eiichi Araki, Masaji Sakaguchi, Kazuki Fukuda, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Global Health & Medicine
|
March 16, 2022
Report on the nature, characteristics, and outcomes of the Japanese healthcare system
Tatsuya Kondo,
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
March 20, 2010
[Development and evaluation of new drugs and medical devices in Japan--standpoint of regulatory agency]
Hiroshi Maruyama, Tatsuya Kondo
Studies in Health Technology and Informatics
|
October 4, 2007
Risk management and measuring productivity with POAS--point of act system
Masanori Akiyama, Tatsuya Kondo
The Journal of Biological Chemistry
|
June 18, 2004
Altered insulin signaling in retinal tissue in diabetic states
Tatsuya Kondo, C Ronald Kahn
Nihon Hoshasen Gijutsu Gakkai Zasshi
|
October 29, 2025
[Proposal of a Mathematical Model for Motion Blur in MRI Images]
Tatsuya Kondo, Hiroaki Saito, Tsutomu Kanazawa
Masui. the Japanese Journal of Anesthesiology
|
October 2, 2015
[Anesthetic Management of a Patient for Total Gastrectomy after Coronary Artery Bypass Grafting Using the Right Gastroepiploic Artery]
Hanae Maejima, Gaku Inagawa, Tatsuya Kondo
Clinical Pharmacology and Therapeutics
|
August 9, 2012
International vision and strategy for drug regulatory authority: the PMDA's international vision
Toshiyoshi Tominaga, Yuki Ando, Tatsuya Kondo
Medical Science Educator
|
May 12, 2025
Pilot Study on Using Large Language Models for Educational Resource Development in Japanese Radiological Technologist Exams
Tatsuya Kondo, Masashi Okamoto, Yohan Kondo
Molecular and Cellular Biology
|
June 1, 2004
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
Kohjiro Ueki, Tatsuya Kondo, C Ronald Kahn
Journal of Diabetes Investigation
|
August 30, 2022
Potential of a glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
Eiichi Araki, Masaji Sakaguchi, Kazuki Fukuda, et al.
Page
of 13